Inside-America

Inside-America

By TRT World
Download on the App Store

Inside-America episodes

  • Crisis Over Ukraine | Inside America with Ghida Fakhry
    The US and UK accuse Russia of planning further military incursions into Ukraine — but has NATO provoked the current crisis?
    Guests: Ivo Daalder, Former US Ambassador to NATO, Brig Gen (ret.) Peter B. Zwack, and Andrew Bacevich, President, Quincy Institute for Responsible Statecraft.
    26 min
  • The US Defence Business | Inside America with Ghida Fakhry
    The United States has had, over the last seventy-five years, the largest defense budget in the world. And it keeps growing. Last week, the US Senate passed the largest military-spending bill since World War Two.
    Guests:
    Marcy Winograd
    Coordinator of Code Pink Congress
    Lawrence Korb
    Senior Fellow at The Center for American Progress
    Gordon Adams
    Fellow at The Quincy Institute
    27 min
  • The Colour of Justice | Inside America with Ghida Fakhry
    The trials of Kyle Rittenhouse and Ahmaud Arbery’s killers have reignited debates across the United States about racial disparities in America’s criminal justice system and whether it ought to be reformed, especially in respect of self-defense.
    Guests:
    Joe Feagin
    Author of "The White Racial Frame" & Distinguished Professor of Sociology at Texas A&M University
    David Bowen
    Member of the Wisconsin State Assembly (D)
    Dontae Sharpe
    Spent 26 years in prison for a wrongful conviction & Fellow with Forward Justice
    26 min
  • The Trump Equation | Inside America with Ghida Fakhry
    Republican Senate Minority leader Mitch McConnell is predicting that his party will have “very good” results in next year’s midterm elections and could possibly win both the House and Senate.
    The Republican confidence about the midterms was reflected in a recent survey released earlier this month which showed Republicans leading Democrats by 10 points —51% to 41%— in the 2022 generic congressional ballot. That is the largest margin in the 40-year history of the survey.
    Other recent polls show that more Americans want to see the Republican Party take control of the House and Senate next year. And while a majority of registered American voters —71 percent— say the U.S. is "off on the wrong track"; only 22 percent believe the country is headed in the right direction.
    But one central —and sensitive— issue that confronts and divides Republicans is Donald Trump.
    The former president who has recently signaled a possible presidential run in 2024, has been holding rallies and raising large sums of money. He remains a strong voice, and at the core of the Grand Old Party’s internal politics.
    His favorability rating among Republican voters stands at 86%. Just 10% hold an unfavorable view of the former President [poll]. A survey conducted just last month found that 47% of Republican voters would vote for Trump; no other candidate was above 13%. The same poll found that 67% of Republican registered voters want Trump to run again.
    So given Trump’s continuing popularity with the base of the party, what should the strategy of the wider Republican Party be?
    Guests:
    Michael Steele
    Former Republican National Committee Chairperson
    Ron Nehring
    Former California Republican Party Chairperson
    26 min
  • The Pharma Industrial Complex | Inside America with Ghida Fakhry
    It is one of the key provisions in President Biden’s Build Back Better legislation, which is expected to be voted on this week in the House of Representatives, and something Democrats have been working on for several decades: how to regulate and lower the price of prescription medication in the United States.
    According to a new report, prescription drugs in the US are, on average, 256% times higher overall than 32 other countries. US prices are 170% higher than they are in Mexico and 779% higher than they are in Turkey. For brand-name drugs, the gap is even higher: 344%.
    Earlier this month, Congressional Democrats managed to revise and save a reform proposal on prescription drugs that was originally dropped from the Build Back Better Act, Biden’s wide-ranging social spending bill. Under the new plan, the US government would negotiate the cost of 10 drugs starting in 2025, and Pharmaceutical companies would be penalized for price hikes exceeding the inflation rates. The original plan to allow the government to negotiate the price of, first, 25, and then 50 prescription drugs, would have saved, according to the White House, $450 billion over ten years; under the agreed plan, those savings will amount to $250 billion.
    Guests:
    Raja Krishnamoorthi
    US Congressman from Illinois (D)
    Saul Anuzis
    President of the 60 Plus Association
    David Mitchell
    President and Founder of Patients for Affordable Drugs
    26 min
  • Parties Under Pressure | Inside America with Ghida Fakhry
    Brad Raffensberger, Georgia’s Republican Secretary of State, was the target of one of President Trump’s efforts to question the fairness and integrity of Georgia’s election count. In his new book, “Integrity Counts”, Brad Raffensperger, a lifelong Republican, speaks out against Trump’s claims of voter fraud in the 2020 election, and blames both parties for undermining trust in the democratic process.
    Also on this show: With just under a year until the critical mid-term elections in November 2022 , Republicans and Democrats are focusing their attention on the crucial forthcoming congressional, gubernatorial, state and local elections. All 435 seats in the House of Representatives and 34 of 100 seats in the Senate are up for grabs. As it stands today, the Senate is split 50/50 with Vice President Kamala Harris, the President of the US Senate, holding the deciding vote.
    Guests:
    Brad Raffensperger
    Georgia Secretary of State & Author of "Integrity Counts"
    Jim Moran
    Former US Congressman from Virginia (D)
    Sam Rasoul
    Member of the Virginia House of Delegates (D)
    26 min

About Inside-America

From the publisher's feed

Weekly in-depth interviews with American opinion and policy-makers exploring the issues shaping US politics, with Ghida Fakhry.​